To this end, it has been proposed that upregulation of UCPsin cancer may be directly related to the antioxidative capacity of skeletal muscle, thusinvolving UCPs in a counter-regulatory mechanism to lower ROS production; this process isthought to involve the muscle anabolic cytokine IL-15 (16). The gene discussed is IL15; the disease is cancer.